# Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis

> **NCT03342807** · PHASE4 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 220 (estimated)

## Conditions studied

- Pancreatitis, Acute
- Hypertriglyceridemia

## Interventions

- **DRUG:** Insulin
- **DEVICE:** Aphesis

## Key facts

- **NCT ID:** NCT03342807
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11
- **Primary completion:** 2019-11
- **Final completion:** 2020-11
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2017-11-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03342807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03342807, "Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03342807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*